The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 368.50
Bid: 368.00
Ask: 369.00
Change: 4.00 (1.10%)
Spread: 1.00 (0.272%)
Open: 358.00
High: 369.50
Low: 358.00
Prev. Close: 364.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Nov 2018 07:00

RNS Number : 9519H
Breedon Group PLC
21 November 2018
 

21 November 2018

 

BREEDON GROUP PLC ("Breedon" or "the Group")

Trading Update

 

Trading performance

 

Breedon delivered another solid performance in the 10 months to 31 October 2018, with increased revenues, improved underlying EBIT and continuing strong cash generation, despite the challenges of a flat construction market in Great Britain ("GB") and rising input costs.

 

Group sales volumes of aggregates increased by 21 per cent and asphalt by 45 per cent compared with the prior year. In common with the rest of the market our concrete volumes declined, by 5 per cent. Our cement business performed in line with our expectations1.

 

Group revenues grew by 32 per cent to approximately £739 million, including just over six months' contribution from the former Lagan Group, which traded strongly. The integration of this business is progressing well and we remain confident of delivering the anticipated synergies.

 

Assuming normal weather conditions for the remainder of the financial year, the Group's underlying EBIT for the full year is expected to be in line with current market expectations2.

Outlook

 

Forecasters expect GB construction output to be flat in 2018 and to grow modestly next year before picking up pace in 2020. Output in Northern Ireland is forecast to increase steadily over the same period, while the Republic of Ireland is expected to deliver double-digit growth.

 

We continue to commit substantial investment across our business, which brings us ongoing benefits in terms of enhanced performance and improved productivity. Whilst we are mindful of the likelihood of continuing cost pressures next year, coupled with the unpredictability of the outcome of the Brexit negotiations, we have consistently demonstrated our ability to deliver value for our shareholders, irrespective of market conditions. Accordingly, sustained organic improvement, continuing strong cash generation and our broadening geographical exposure, together with the potential for further bolt-on acquisitions, give us confidence that we will make further progress in 2019.

 

We will announce our preliminary results for the year ending 31 December 2018 on 6 March 2019.

 

- ends -

 

 

1 In accordance with the Cement Market Data Order 2016, cement volumes are not disclosed.

2 The Group believes that current market expectations for underlying EBIT range from £100 million to £103 million. 

 

For further information:

Breedon Group plc

Pat Ward, Group Chief ExecutiveRob Wood, Group Finance Director01332 694444

Stephen Jacobs, Head of Communications07831 764592 

Cenkos Securities plcMax Hartley (Nomad)020 7397 8900 

Numis Securities (joint broker)

Heraclis Economides/Ben Stoop020 7260 1000

 

Note to editors

 

Breedon Group plc is a leading construction materials group in the UK and Ireland. It currently operates two cement plants, around 80 quarries, 40 asphalt plants, 170 ready-mixed concrete and mortar plants, nine concrete and clay products plants, four contract surfacing businesses, six import/export terminals and two slate production facilities.

The Group employs nearly 3,000 people and has nearly 900 million tonnes of mineral reserves and resources. The group's strategy is to continue growing organically and through the acquisition of businesses in the heavyside construction materials market.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTURRNRWNAAUAA
Date   Source Headline
4th Jun 20191:01 pmRNSDirector / PDMR Dealings & Total Voting Rights
29th May 201912:38 pmRNSFurther re: Intended Sale of Shares
29th May 20197:05 amRNSIntended Sale of Shares
29th May 20197:00 amRNSDirectorate Change
7th May 20195:05 pmRNSDirector / PDMR Dealings & Total Voting Rights
30th Apr 20192:39 pmRNSResult of AGM
30th Apr 20197:00 amRNSAGM Statement
16th Apr 201910:14 amRNSDirectors' and PDMRs' Dealings
8th Apr 20193:12 pmRNSDirector and PDMR Dealings & Issue of Equity
2nd Apr 201912:02 pmRNSDirector and PDMR Dealings and Issue of Equity
1st Apr 20195:00 pmRNSGrant of SAYE Options and PDMR Dealings
18th Mar 20199:23 amRNSDirector Dealings
6th Mar 20197:00 amRNSAnnual Results 2018
15th Feb 201910:53 amRNSHolding(s) in Company
23rd Jan 20192:30 pmRNSBlock listing Interim Review
18th Dec 201811:20 amRNSDirectorate Change
17th Dec 201810:20 amRNSDirector/PDMR Shareholding
14th Dec 20183:46 pmRNSDirector/PDMR Shareholding
12th Dec 20182:27 pmRNSDirector/PDMR Shareholding
7th Dec 20181:00 pmRNSDirector/PDMR Shareholding
6th Dec 20184:57 pmRNSDirector/PDMR Shareholding
27th Nov 201812:00 pmRNSTotal Voting Rights
21st Nov 20187:00 amRNSTrading Update
23rd Oct 20183:55 pmRNSDirector/PDMR Shareholding
17th Oct 20184:42 pmRNSDirector/PDMR Shareholding
16th Oct 20185:00 pmRNSGrant of SAYE Options and PDMR Dealings
12th Oct 201810:00 amRNSDirector/PDMR Shareholding
1st Oct 20188:05 amRNSAppointment of Non-Executive Director
25th Sep 20184:17 pmRNSDirector/PDMR Shareholding
14th Sep 20183:21 pmRNSHolding(s) in Company
14th Sep 20183:20 pmRNSHolding(s) in Company
5th Sep 20187:01 amRNSAppointment of Non-Executive Director
5th Sep 20187:00 amRNSHalf-year Report
1st Aug 20183:57 pmRNSHolding(s) in Company
25th Jul 20182:58 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSBlock Listing Update
2nd Jul 20187:00 amRNSBREEDON COMPLETES ASSET SWAP WITH TARMAC
1st Jun 20185:30 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSAcquisition of Blinkbonny Quarry
17th May 20184:55 pmRNSGrant of SAYE Options and PDMR Dealings
11th May 20183:30 pmRNSResults of Open Offer
8th May 201812:49 pmRNSDirector and PDMR Dealings
30th Apr 20184:19 pmRNSDirector/PDMR Shareholding
27th Apr 20182:18 pmRNSAdditional Block Listing of Ordinary Shares
26th Apr 20181:29 pmRNSDirector and PDMR Dealings and Issue of Equity
26th Apr 20188:00 amRNSCMA's Review of Proposed Acquisition
24th Apr 20183:54 pmRNSResult of AGM
24th Apr 201812:15 pmRNSAppointment of Deputy Chairman
24th Apr 20187:00 amRNSAGM Statement
23rd Apr 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.